A detailed history of Entropy Technologies, LP transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Entropy Technologies, LP holds 7,905 shares of CRSP stock, worth $365,922. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,905
Previous 15,402 48.68%
Holding current value
$365,922
Previous $832 Million 55.36%
% of portfolio
0.04%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$44.62 - $62.75 $334,516 - $470,436
-7,497 Reduced 48.68%
7,905 $371 Million
Q2 2024

Aug 12, 2024

SELL
$51.17 - $68.18 $505,457 - $673,482
-9,878 Reduced 39.07%
15,402 $832 Million
Q1 2024

May 08, 2024

BUY
$60.67 - $89.12 $1.53 Million - $2.25 Million
25,280 New
25,280 $1.72 Billion

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.61B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Entropy Technologies, LP Portfolio

Follow Entropy Technologies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entropy Technologies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Entropy Technologies, LP with notifications on news.